We recently published a list of 10 Firms End 2024 Stronger With Impressive Gains. In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) against other firms end 2024 ...

In this article, we are going to take a look at where Roivant Sciences Ltd. (NASDAQ:ROIV) against other firms end 2024 stronger with impressive gains. A lackluster trading persisted throughout the ...

Eric Venker, President & COO at Roivant Sciences ROIV, reported a large exercise of company stock options on January 1, according to a new SEC filing. What Happened: A Form 4 filing with the U.S ...

"Forgive us our trespasses: grant us your peace" is Pope Francis' theme for the World Day of Peace, today, Jan. 1, 2025. His plea is for a year blessed by forgiveness — forgiveness between ...

If you’re on the fence about investing in Roivant Sciences Ltd., Veracyte or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

In other Roivant Sciences news, COO Eric Venker sold 100,000 shares of the stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $11.32, for a total value ...

JPMorgan Chase & Co. grew its holdings in shares of Roivant Sciences by 4.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 822,582 shares of the company’s stock worth $9,493,000 after ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...